Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Zhile Capsules for major depressive disorder
CTR20244526Phase 2Completed
- Sponsor
- 浙江施强制药有限公司
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of agomelatine in major depressive disorder (MDD), sponsored by 浙江施强制药有限公司. Started Jan 2025; status: completed.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20244526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244526.